What is the recommended treatment regimen for syphilis at each stage, including considerations for pregnancy, penicillin allergy, and HIV co‑infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Syphilis

Benzathine penicillin G remains the only proven effective treatment for all stages of syphilis, with dosing and duration determined by disease stage, and no acceptable alternatives exist for pregnant patients. 1

Primary, Secondary, and Early Latent Syphilis (< 1 year duration)

Administer benzathine penicillin G 2.4 million units intramuscularly as a single dose. 1, 2 This regimen achieves 90-100% treatment success rates in most patients. 3

Special Considerations for HIV Co-infection

  • Use the same single-dose benzathine penicillin G regimen (2.4 million units IM once) for HIV-positive patients with early syphilis. 1, 4
  • Do not routinely add extra doses—a randomized trial demonstrated that three weekly doses provided no additional benefit over single-dose therapy in HIV-infected individuals (93% vs 80% success, P=0.17). 4
  • However, intensify monitoring: obtain clinical assessment and quantitative nontreponemal serology at 3,6,9,12, and 24 months after treatment. 1
  • If titers fail to decline fourfold by 3 months, perform lumbar puncture and consider retreatment with benzathine penicillin G 7.2 million units (three weekly doses of 2.4 million units). 1

Late Latent Syphilis and Syphilis of Unknown Duration

Administer benzathine penicillin G 7.2 million units total, given as 2.4 million units IM weekly for three consecutive weeks. 1, 2

Critical Pre-Treatment Evaluation

Before initiating therapy, evaluate for neurologic, ocular, or auditory symptoms—any such findings mandate CSF examination and treatment as neurosyphilis. 1

In HIV-infected patients with late latent syphilis, strongly consider CSF examination before treatment to exclude asymptomatic neurosyphilis, as this population has higher risk of CNS involvement. 1

Neurosyphilis, Ocular Syphilis, and Otic Syphilis

Administer aqueous crystalline penicillin G 18-24 million units per day (given as 3-4 million units IV every 4 hours) for 10-14 days. 1

Alternative Regimen (when IV access is problematic)

  • Procaine penicillin 2.4 million units IM once daily plus probenecid 500 mg orally four times daily, both for 10-14 days. 1
  • Some experts add benzathine penicillin G 2.4 million units IM weekly for up to 3 weeks after completing the IV/IM course to provide comparable total duration. 1

Neurosyphilis Follow-Up

  • If CSF pleocytosis was present initially, repeat CSF examination every 6 months until cell count normalizes. 1
  • If cell count has not decreased after 6 months or CSF is not normal after 2 years, retreatment is indicated. 1

Tertiary (Gummatous or Cardiovascular) Syphilis

Administer benzathine penicillin G 7.2 million units total (three weekly doses of 2.4 million units IM). 1

Perform CSF examination before initiating therapy to exclude neurosyphilis, as symptomatic tertiary disease requires this evaluation. 1 Some experts recommend treating all cardiovascular syphilis with the neurosyphilis regimen (IV aqueous crystalline penicillin G). 1 Consultation with an infectious disease specialist is advised. 1

Treatment in Pregnancy

Pregnant women must receive parenteral penicillin G—it is the only therapy with documented efficacy for preventing congenital syphilis. 5, 6, 7

Stage-Specific Regimens

  • Primary, secondary, or early latent syphilis: Benzathine penicillin G 2.4 million units IM as a single dose. 7
    • Some experts recommend an additional dose of 2.4 million units IM one week later, particularly in the third trimester or when treating secondary syphilis. 1, 7
  • Late latent or unknown duration: Benzathine penicillin G 7.2 million units total (three weekly doses of 2.4 million units IM). 7

Critical Pregnancy-Specific Precautions

  • Treatment must occur more than 4 weeks before delivery for optimal fetal outcomes. 1
  • Warn patients to seek immediate obstetric care if they experience fever, uterine contractions, or decreased fetal movements within 24 hours of treatment—these may signal a Jarisch-Herxheimer reaction. 6, 7
  • For gestations beyond 20 weeks, consider fetal and uterine-contraction monitoring for 24 hours after treatment, especially when ultrasound suggests possible fetal infection. 7
  • Do not delay treatment due to fear of Jarisch-Herxheimer reaction—untreated syphilis poses far greater fetal risk. 7

Screening Requirements in Pregnancy

  • Screen all pregnant women at the first prenatal visit. 7
  • In high-risk populations or high-prevalence areas, perform additional screening at 28-32 weeks gestation and at delivery. 7, 2
  • Repeat serologic titers in the third trimester and at delivery; consider monthly titers in women at high risk of reinfection. 7
  • No newborn should be discharged without documented maternal syphilis screening at least once during pregnancy. 1, 7

Management of Penicillin Allergy

In Pregnant Patients

Penicillin desensitization is mandatory—there are no acceptable alternatives for treating syphilis in pregnancy. 1, 6, 7

  • Perform skin testing followed by desensitization before penicillin administration. 6, 7
  • Never use tetracyclines (including doxycycline) in pregnancy—they cause maternal hepatotoxicity and fetal bone/tooth staining. 1, 6
  • Never use erythromycin—it does not reliably cure fetal infection. 1, 6
  • Azithromycin and ceftriaxone are inadequate and do not prevent congenital syphilis. 1

In Non-Pregnant Patients

For early syphilis (primary, secondary, or early latent):

  • Doxycycline 100 mg orally twice daily for 2 weeks is the preferred alternative. 1
  • Tetracycline 500 mg orally four times daily for 2 weeks is an alternative. 1

For late latent syphilis:

  • Doxycycline 100 mg orally twice daily for 4 weeks. 1
  • Tetracycline 500 mg orally four times daily for 4 weeks is an alternative. 1

Critical Caveat for Non-Penicillin Regimens

Perform lumbar puncture (CSF examination) before using any non-penicillin regimen to exclude neurosyphilis, as these alternatives are ineffective for CNS disease. 1

The efficacy of doxycycline or tetracycline in HIV-infected patients has not been studied—use with extreme caution and ensure close follow-up. 1

Monitoring Treatment Response

Definition of Treatment Success

A fourfold (two-dilution) decline in quantitative nontreponemal test titers (e.g., from 1:32 to 1:8) indicates successful treatment. 1

Follow-Up Schedule

  • Primary and secondary syphilis: Clinical and serological evaluation at 6 and 12 months. 1
  • Latent syphilis: Evaluation at 6,12,18, and 24 months. 1
  • HIV-infected patients: More intensive monitoring at 3,6,9,12, and 24 months. 1

Expected Timeline for Serologic Response

  • Early syphilis: Titers should decline by 6 months. 3
  • Latent syphilis: Response is slower, typically 12-24 months. 3

Indications for Retreatment

Retreatment is indicated if:

  • Nontreponemal titers increase fourfold (two dilutions) from the post-treatment nadir. 1
  • An initial titer ≥1:32 fails to decline fourfold within 12-24 months. 1
  • New clinical signs or symptoms of syphilis develop. 1

When retreatment is needed, perform lumbar puncture before retreating to exclude neurosyphilis. 1

Partner Management

Presumptively treat sexual partners exposed within 90 days preceding diagnosis of primary, secondary, or early latent syphilis, even if seronegative. 5, 7 Use the same single-dose benzathine penicillin G regimen. 5

All patients diagnosed with syphilis should be tested for HIV if status is unknown. 1, 2

Common Pitfalls to Avoid

  • Do not use oral penicillin preparations or combinations of benzathine and procaine penicillin—these are not appropriate for syphilis treatment. 5
  • Do not compare RPR and VDRL titers directly—they are not interchangeable, and sequential tests should use the same method and ideally the same laboratory. 1
  • Do not use azithromycin—widespread resistance makes it unreliable. 1
  • Do not skip CSF examination when indicated—failure to diagnose neurosyphilis leads to inadequate treatment and progression of disease. 1
  • If a pregnant woman misses a weekly benzathine penicillin dose, repeat the entire three-dose course to ensure adequate fetal treatment. 1

Jarisch-Herxheimer Reaction

Inform all patients about the Jarisch-Herxheimer reaction—an acute febrile reaction with headache and myalgia that typically occurs within 24 hours of treatment. 5, 1 This reaction is most common in early syphilis. 5 Antipyretics may be used but have not been proven to prevent the reaction. 5 In pregnant women, the reaction may induce early labor or fetal distress, but this concern should never prevent or delay therapy. 5

References

Guideline

Syphilis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Syphilis: A Review.

JAMA, 2025

Research

Single Dose Versus 3 Doses of Intramuscular Benzathine Penicillin for Early Syphilis in HIV: A Randomized Clinical Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Penicillin as the Cornerstone of Managing Tooth Abscess and Syphilis in Pregnant Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Syphilis Treatment in Pregnant Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.